Analyst Reco. GSK plc

Equities

Market Closed - London S.E. Other stock markets 09:05:27 09/07/2025 pm IST			5-day change	1st Jan Change
1,425.00 ^GBX	+0.78%		+0.88%	+5.83%

09/07	FTSE 100 ends slightly higher as investors watch US tariff talks, WPP slumps	RE
09/07	GSK: to present new data on HIV	CF

GSK : UBS reiterates its Neutral rating	03/07	ZD
AlphaValue/Baader Europe Upgrades GSK to Buy, Trims PT	01/07	MT
GSK : UBS reaffirms its Neutral rating	01/07	ZD
GSK : Gets a Neutral rating from Goldman Sachs	30/06	ZD
GSK : JP Morgan reiterates its Sell rating	30/06	ZD
Sadif Investment Analytics Downgrades GSK to Hold, Cuts PT	13/06	MT
GSK : JP Morgan remains a Sell rating	10/06	ZD
GSK : Bernstein keeps its Buy rating	04/06	ZD
Berenberg Downgrades GSK to Hold From Buy, Keeps $41 Price Target	03/06	MT
GSK : Berenberg lowers his opinion and switches to Neutral	03/06	ZD
GSK PLC : Despite its challenges, GSK remains investable	21/05
GSK : Berenberg reiterates its Buy rating	16/05	ZD
GSK : JP Morgan remains a Sell rating	14/05	ZD
GSK : Deutsche Bank reiterates its Neutral rating	14/05	ZD
GSK : Goldman Sachs reiterates its Neutral rating	14/05	ZD
GSK : Deutsche Bank reaffirms its Neutral rating	12/05	ZD
GSK : Sell rating from JP Morgan	01/05	ZD
GSK : Goldman Sachs remains Neutral	01/05	ZD
GSK : JP Morgan reiterates its Sell rating	01/05	ZD
GSK : UBS gives a Neutral rating	01/05	ZD
GSK PLC : A healthy start to 2025; guidance unchanged	30/04
GSK : UBS remains Neutral	30/04	ZD
GSK : Jefferies remains Neutral	30/04	ZD
GSK : Oddo BHF still neutral	30/04	CF
GSK : JP Morgan maintains a Sell rating	30/04	ZD

No results for this search

GSK PLC : Despite its challenges, GSK remains investable

May 21, 2025 at 07:38 pm IST

GSK CEO on US Expansion, M&A, Drug Pipeline, Trump

GSK plc : Back on track

May 03, 2024 at 02:47 pm IST